Localized angiofollicular hyperplasia, othenvise known as Castleman's disease, is described in the lymph nodes of 2 mice of different strains, one inoculated with polyoma virus at birth and the other given urethane within 24 hr ofbirth. A plasma cell component in the lesion, suggestive ofbone marrow stem cell involvement, was present in the mouse treated with polyoma virus but absent in the mouse given intrapentoneal urethane. Dysregulated interleukin 6 has recently been reported to produce the systemic variety of angiofollicular hyperplasia in mice, but the role of this cytokine in the localized variety described in this report is not known. This lesion appears to be rare in mice, but when present it could easily be missed or overlooked because the typical layering of follicle cells and the relatively large germinal centers seen in humans do not appear prominent in mice. Although there is, obviously, no proof of a causal relationship between the lesion and polyoma virus or urethane, it is suggested that this lesion be searched for in order to estimate its frequency and possible etiologic associations.
INTRODU~ION
Angiofollicular lymphoid hyperplasia, otherwise referred to as Castleman's disease (7, 13, 22) , was originally described as an independent, localized lesion in the mediastinum of humans. It has subsequently been observed and described in association with a variety of pathological conditions and syndromes (12, 13, 22) . A lesion resembling Castleman's disease has recently been experimentally produced and described in mice (5, 6), using either the transgenic mouse model carrying an interleukin 6 (IL-6) gene or using retrovirus-mediated transfer of murine IL-6 sequences (6). The recognition of this lesion in a variety of human tissues other than lymph nodes and the systemic manifestations sometimes associated with it have led to the application of several synonyms (1 , 2, 15, 16). The lesion may be unicentric in origin and confined to 1 lymph node, as originally described by Castleman and his colleagues, or it may be multicentric (2, 3, 15, 16) . The relationship between the localized and the multicentric varieties remains poorly understood (1 3), but the histological characteristics in both types remain essentially similar with minor variations. The 2 -basic histologic components of this process in Tym& nodes include hypervascular lymphoid follicular hyperplasia (pseudo-Hassal's corpuscles) and plasmacytosis (3, 4). The lymph node architecture may either be preserved or effaced depending on the stage of development of the lesion. The observed morphologic variations of this lesion may be a reflection of its biological diversity. This may partly explain some of the differences in the clinical and laboratory manifestations known to be frequently associated with either the isolated lesion or systemic, multifocal lesions. The hypotheses proposed for 26 the pathogenesis of this lesion have centered around 3 possible types of etiology, namely, (a) a developmental anomaly (hamartoma) (2, 3), (b) a neoplasm (7, 13), or (c) a postinflammatory reaction (4). Although evidence on clinico-pathologic bases support each of the proposed hypotheses, no animal model with the localized lesion has been described to shed light on its mechanisms and pathogenesis (5,6). The recent observation of Castleman's disease in lymph nodes of patients with retroviral infection, particularly human immunodeficiency virus (HIV) (13, 14, 16), and the association of Castleman's disease with Kaposi's sarcoma in lymph nodes of acquired immunodeficiency syndrome (AIDS) patients (16) provide evidence in support of a postinflammatory reaction to viral infection in some patients. Experimentally induced dysregulation of IL-6 in mice has been shown to produce the systemic lymphoproliferative type of disorder (4-6, 16) that resembles Castleman's disease but not the localized variety (7, 13,22). The hamartomatous or localized variety of Castleman's disease has so far not been reported in laboratory animals.
This article describes localized angiofollicular lymphoid hyperplasia observed in 2 mice of different strains, one infected with polyoma virus and the other exposed to urethane.
MATERIALS AND METHODS
The histological materials studied were accessioned by the Registry of Experimental Cancers at the National Cancer Institute (Bethesda, MD). The first (Accession No. M22468) was a cervical lymph node from a female mouse of inbred strain (Swissderived) NIH. This mouse, within 24 hr after birth, received a high-dose subcutaneous inoculum of uncloned wild-type strain Parotid Tumor Agent (PTA) polyoma virus, whose origin and propagation have been described (1 0). Eight mo later, the mouse came to necropsy because of a visible, palpable cervical swelling that was thought to be a polyoma virusinduced tumor of one of the salivary glands. The mass was spherical, measured about 0.8 cm in diameter, and had the tan, homogenous appearance and soft consistency of a polyoma-induced salivary, gland tumor. No other masses were found elsewher; in the mouse. The second mouse (Accession No. M34440) was a 26 mo old C57BL strain female that had received an intraperitoneal injection of urethane (0.8 mg/g body weight) within 24 hr of birth. At autopsy, the cervical lymph node was enlarged and measured 1.5 x 2.0 cm. Routine sections obtained at autopsy were embedded in paraffin wax, stained with hematoxylin and eosin, aniline blue, and periodic acid-Schiff and for reticulin using the method of Tibor-Pap.
RESULTS
In the polyoma virus-infected mouse, the lymph node architecture was preserved in areas, but 2 features considered to be characteristic of Castleman's disease were observed. There were increased numbers of large-sized follicle center cells (Fig. l) , consistent with hyperplasia, and there was moderate to prominent proliferation of capillaries within and around the follicles (Fig. 2) . The proliferating vessels showed no hyalinization within or outside the germinal centers. In a few areas, there were concentric layers of follicle-center cells surrounded by or interspersed with proliferating capillaries. There was moderate infiltration of plasma cells (Fig. 3) , which lacked specific relationship to the hyperplastic follicles. There was reduction of reticulin fibers within the hyperplastic follicles (Fig. 4) , but the reticulin framework of the proliferating capillaries around the hyperplastic follicles was maintained and preserved (Fig. 4) . The histologic features of the lymphoid lesions are consistent with the diagnosis of localized Castleman's disease, thus confirming the microscopic diagnosis of angiofollicular lymph node hyperplasia made by the initial investigators and Dr. Clyde. J. Dawe and confirmed by Dr. Elaine Jaffe. This mouse, inoculated with polyoma virus, had the plasmacytic variant of Castleman's disease, but typical pseudo-Hassal's corpuscles were not present in the lymph node.
In the urethane-exposed mouse, similar histopathological features of localized Castleman's disease were seen, but there was a lack of plasmacytosis ( Fig. 5) and only a few vessels showed hyalinization (Fig. 6) . The concentric layering of follicle cells was observed around capillaries, particularly around the few hyalinized blood vessels (Fig. 6 ). Capillary proliferation was also prominent even in the absence of concentric layering of follicle cells (Fig. 7) . In both mice, the focal areas of follicular hyperplasia had relatively inconspicuous germinal centers (Figs. 1 and 5), and all the other tissues examined showed no evidence of angiofollicular hyperplasia. In the absence of other manifestations known to be associated with Castleman's disease, it was evident that this was a localized lesion. DISCUSSION Castleman's disease in humans may be characterized either by a solitary lymphoid mass that is usually nonrecuning after surgical resection (2) or by multicentric lesions associated with systemic lymphoproliferative manifestations that constitute a severe and invariably fatal condition (1 4, 16, 17). There is evidence in humans indicating that inappropriate synthesis of JL-6 may be responsible for the pathogenesis of this process regardless of whether it is localized or systemic in distribution (34). Experimental evidence in support of this hypothesis has come from recent studies on mice given transplants of bone marrow cells infected with retrovirusmediated IL-6 sequences, resulting in a multicentric form of Castleman's disease similar to the disseminated form described in humans (5, 6). In the experimental mice, however, the germinal centers were atretic, whereas germinal centers were invariably prominent in humans (Fig. 8) . It has been suggested that abnormal proliferating B cells may be responsible for the secretion of the cytokine, IL-6 (5, 6). However, the origin of the plasma cell variant of Castleman's disease, in the mouse, has been attributed to a bone marrow-derived cell that repopulates either the lymph nodes or the spleen. The demonstration of retroviral RNA species in organs infil- disease and indistinguishable from lesions resulting from retrovirus-mediated transfer of murine IL-6 sequences (5, 6).
The affected lymph nodes from the 2 mice with angiofollicular lymphoid hyperplasia reported in this paper showed the diagnostic findings of follicular hyperplasia and vascular proliferation that are consistent with Castleman's disease. The polyoma virus-inoculated mouse had, in addition to these 2 features, the plasma cell feature, which may be re- lated to the effect of the polyoma virus on the bone marrow stem cell. The affected lymph node in the urethane-exposed mouse was devoid of plasmacytosis. The development of this process in these 2 mice is compatible with the hypothesis that Castleman's disease is essentially a host reaction to a variety of stimuli mediated by different cytokines of which IL-6 has recently been shown to be significant 5, 6, 33, 34) . In the animal inoculated with polyoma virus, the development of the plasma cell variant of Castleman's disease may be due to integration of the viral DNA into bone marrow-derived stem cells in which paracrine stimulation of B-cell proliferation and differentiation is thought to occur (6). Neither of the 2 animals showed evidence of B-cell lymphoma or multiple myeloma, conditions that have also been associated with the natural history of Castleman's disease in humans (23, 25, 33) .
The concentric layering of follicle cells observed in both mice was not as prominent (Fig. 6 ) as in human lesions, which are usually characterized by prominent germinal centers with hyalinized blood vessels (Fig. 8) . Therefore, this feature, which is considered pathognomonic of Castleman's disease, could be easily missed in murine lesions. In the mouse exposed to urethane, the areas of proliferating nonhyalinized blood vessels (Fig. 7) simulated early stages of lymph node angiomatosis (1 1).
It is conceivable that urethane may have predisposed to increased proliferation of abnormal B cells secreting IL-6 but without involvement of hematopoietic stem cells, which would be in contrast to the case of the virus-infected mouse. IL-6 is synthesized in response to a number of stimuli that include viruses and also to other cytokines that may have overlapping biological activities (24, (27) (28) (29) . The present observations in 2 mice, obviously, do not provide evidence that polyoma virus or urethane is the etiological agent responsible for the development of this lesion. However, dysregulated IL-6 expression has been associated with a number of human diseases including psoriasis (1 8), rheumatoid arthritis (21), Kaposi's sarcoma (8, 32) (Fig. 8), and mesangioproliferative glomerulonephritis (30) as well as Castleman's disease (8, 20) . It has also been suggested that IL-6 acts as an autocrine or paracrine growth factor in the development of different types of neoplasia in humans (23, 25, 33) . Clonal immunoglobulin gene rearrangements (1 9) have been observed in some patients with multicentric Castleman's disease, and a proportion of these patients develop multiple myeloma (1 6'17). Similar studies are required in experimental animals in order to elucidate the possible roles of cytokines and genetic factors in neoplasia (9).
Nodal lesions identical to the plasmacytic variant of Castleman's disease have been observed in Wiskott-Aldrich syndrome, drainage sites of carcinomas or lymphomas, vaccination sites, lipoid nephrosis, and peripheral vascular diseases (1 3). In view of the diverse diseases known to be associated with Castleman's disease with varying frequencies, the diagnosis of primary or idiopathic Castleman's disease should only be made after other possible associated primary causes have been excluded (1 3) . While the follicular hyperplasia may be attributable to IL-6, the unusual vascular proliferation may be due either to the effect of the same multifunctional cytokine or to angiogenic factors or other related cytokines (9).
There is general consensus that Castleman's disease, the plasmacytic type, represents a reactive postinflammatory process in humans. Agents that have been incriminated in humans as possible etiologic agents include Epstein-Barr virus, toxoplasmosis, and mycobacterium tuberculosis (1 3). No data indicate the etiologic agents responsible for this process in rodents or other laboratory animals. No investigator had encountered this type of lesion, although several thousand mice inoculated with polyoma virus had been examined during a period of more than 25 yr (Dr. Clyde J. Dawe, personal communication) .
The finding of angiofollicular hyperplasia in the lymph nodes of patients with HIV infection and AIDS (8, 26, 32) (Fig. 8) provides some evidence of retrovirus-mediated expression of IL-6. However, the relative lack of plasma cells in this lesion in a proportion of AIDS patients may reflect, in those cases, a lack of integration of HIV-DNA into the bone marrow-derived cells leading to plasma cell differentiation. Nevertheless, increased frequencies of B-cell lymphomas, plasmacytosis, and multiple myeloma have been described in patients with AIDS (16, 32) . It is conceivable that in these patients there is HIV-DNA integration in hematopoietic cells with expression of IL-6 that may act as a co-factor with certain oncogenes, particularly c-myc. This mechanism has been shown to be important in the development of plasmacytomas in pristine-injected mice (9). The search for experimental animal models with angiofollicular hyperplasia or Castleman's disease should be pursued with the objective of identifying causative agents and understanding the mechanisms involved in the evolution of the process, which may potentially be an antecedent lesion in lymphomagenesis.
We believe that this is the first report of localized Castleman's disease occurring in mice. The observacon of this lesion in mice of different strains, 1 inbred and 1 noninbred, treated with different agents, suggests that attention should be paid to the features of Castleman's disease in experimental studies resulting in murine lymphadenopathy. No evidence confirms that the observed lesions were mediated by IL-6 or other cytokines. Further studies are required to elucidate the role of cytokines and viruses (8, 27, 29, 32) in the pathogenesis of Castleman's disease with or without plasma cell infiltration (26, 3 1) .
